Today, the U.S. Food and Drug Administration authorized Wegovy (semaglutide) injection (two.four mg as soon as weekly) for chronic weight administration in adults with being overweight or overweight with at the least just one weight-connected condition (for instance high blood pressure, type two diabetes, or high cholesterol), to be used Besides a